The DOI matches its Crossref record; 603 of the 603 references it cites were found in a registry or an index.
Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
Open accessAbstract
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest over the last decades. In particular, the analysis of biomarkers in cancer patients within the pre- and post-therapeutic period is required to identify several types of cells, which carry a risk for a disease progression and subsequent post-therapeutic relapse. Cancer stem cells (CSCs) are a subpopulation of tumor cells that can drive tumor initiation and can cause relapses. At the time point of tumor initiation, CSCs originate from either differentiated cells or adult tissue resident stem cells. Due to their importance, several biomarkers that characterize CSCs have been identified and correlated to diagnosis, therapy and prognosis. However, CSCs have been shown to display a high plasticity, which changes their phenotypic and functional appearance. Such changes are induced by chemo- and radiotherapeutics as well as senescent tumor cells, which cause alterations in the tumor microenvironment. Induction of senescence causes tumor shrinkage by modulating an anti-tumorigenic environment in which tumor cells undergo growth arrest and immune cells are attracted. Besides these positive effects after therapy, senescence can also have negative effects displayed post-therapeutically. These unfavorable effects can directly promote cancer stemness by increasing CSC plasticity phenotypes, by activating stemness pathways in non-CSCs, as well as by promoting senescence escape and subsequent activation of stemness pathways. At the end, all these effects can lead to tumor relapse and metastasis. This review provides an overview of the most frequently used CSC markers and their implementation as biomarkers by focussing on deadliest solid (lung, stomach, liver, breast and colorectal cancers) and hematological (acute myeloid leukemia, chronic myeloid leukemia) cancers. Furthermore, it gives examples on how the CSC markers might be influenced by therapeutics, such as chemo- and radiotherapy, and the tumor microenvironment. It points out, that it is crucial to identify and monitor residual CSCs, senescent tumor cells, and the pro-tumorigenic senescence-associated secretory phenotype in a therapy follow-up using specific biomarkers. As a future perspective, a targeted immune-mediated strategy using chimeric antigen receptor based approaches for the removal of remaining chemotherapy-resistant cells as well as CSCs in a personalized therapeutic approach are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CSCs are a subpopulation of tumor cells with the capacity for sustained self-renewal that, in turn, can not only drive tumor initiation but can also cause relapses, metastasis, and resistance to therapy [82,83].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–400 of 603
Zhang, L., Xu, L., Zhang, F., & Vlashi, E. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1241929 · Cited by 110
Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis
Siddharth, S., Goutam, K., Das, S., et al. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.06.007 · Cited by 110
Bocchia, M., Sicuranza, A., Abruzzese, E., Iurlo, A., Sirianni, S., Gozzini, A., Galimberti, S., Aprile, L., Martino, B., Pregno, P., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00194 · Cited by 110
Cirulli, V., Crisá, L., Beattie, G. M., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1519 · Cited by 109
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
Collina, F., Bonito, M. D., Bergolis, V. L., et al. (2015) · BioMed Research International · doi:10.1155/2015/158682 · Cited by 109
Zhang, X., Hua, R., Wang, X., Huang, M., Gan, L., Wu, Z., Zhang, J., Wang, H., Cheng, Y., Li, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6890 · Cited by 109
Oh, K., Lee, O.-Y., Park, Y., Seo, M. W., & Lee, D. (2016) · BMC Cancer · doi:10.1186/s12885-016-2746-7 · Cited by 109
Leukemia stem cells: the root of chronic myeloid leukemia
Zhou, H., & Xu, R. (2015) · Protein & Cell · doi:10.1007/s13238-015-0143-7 · Cited by 108
Baker, A. T., Wyatt, D. L., Bocchetta, M., Li, J., Filipović, A., Green, A. R., Peiffer, D. S., Fuqua, S. A. W., Miele, L., Albain, K. S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0251-y · Cited by 108
Lee, J. H., Yun, C. W., Han, Y., Kim, S., Jeong, D., Kwon, H. Y., Kim, H., Baek, M. J., & Lee, S. H. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12519 · Cited by 107
Cho, Y., Lee, H.-W., Kang, H.-G., Kim, H., Kim, S.-J., & Chun, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3325 · Cited by 106
Klapdor, R., Wang, S., Hacker, U. T., Büning, H., Morgan, M. A., Dörk, T., Hillemanns, P., & Schambach, A. (2017) · Human Gene Therapy · doi:10.1089/hum.2017.168 · Cited by 105
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
Zhang, Q., Tian, K., Xǔ, J., Zhang, H., Li, L., Fu, Q., Chai, D., Li, H., & Zheng, J. (2017) · Journal of Immunology Research · doi:10.1155/2017/6915912 · Cited by 105
Ang, W. X., Li, Q., Chi, Z., Du, S., Chen, C., Tay, J. C.-K., Toh, H. C., Connolly, J. E., Xu, X., & Wang, S. (2017) · Oncotarget · doi:10.18632/oncotarget.14592 · Cited by 104
Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
Janghorban, M., Xin, L., Rosen, J. M., & Zhang, X. H.-F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01649 · Cited by 104
Sox2 is associated with cancer stem-like properties in colorectal cancer
Takeda, K., Mizushima, T., Yokoyama, Y., Hirose, H., Wu, X., Qian, Y., Ikehata, K., Miyoshi, N., Takahashi, H., Haraguchi, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-36251-0 · Cited by 104
Nievergall, E., Ramshaw, H. S., Yong, A. S. M., Biondo, M., Busfield, S. J., Vairo, G., Lopez, A. F., Hughes, T. P., White, D. L., & Hiwase, D. (2013) · Blood · doi:10.1182/blood-2012-12-475194 · Cited by 103
Characterization of LGR5 stem cells in colorectal adenomas and carcinomas
Baker, A., Graham, T. A., Elia, G., Wright, N. A., & Rodriguez‐Justo, M. (2015) · Scientific Reports · doi:10.1038/srep08654 · Cited by 103
Bhola, N. E., Jansen, V. M., Koch, J. P., Li, H., Formisano, L., Williams, J. A., Grandis, J. R., & Arteaga, C. L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1640-t · Cited by 103
Gastric Lgr5+ stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice
Li, X.-B., Yang, G., Zhu, L., Tang, Y., Zhang, C., Ju, Z., Yang, X. Y., & Teng, Y. (2016) · Cell Research · doi:10.1038/cr.2016.47 · Cited by 103
Warda, W., Larosa, F., Rocha, M. N. D., Trad, R., Deconinck, É., Fajloun, Z., Faure, C., Caillot, D., Moldovan, M., Valmary‐Degano, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1078 · Cited by 103
Dai, X., Ge, J., Wang, X., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.2086 · Cited by 102
Qiu, X., Wang, Z., Li, Y., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.004 · Cited by 102
Lundberg, I. V., Edin, S., Eklöf, V., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2509-5 · Cited by 102
Kamimoto, K., Kaneko, K., Kok, C., Okada, H., Miyajima, A., & Itoh, T. (2016) · eLife · doi:10.7554/elife.15034 · Cited by 102
Li, F., Sutherland, M. K., Yu, C., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0742 · Cited by 102
Bertolini, G., D’Amico, L., Moro, M., Landoni, E., Perego, P., Miceli, R., Gatti, L., Andriani, F., Wong, D., Caserini, R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3781 · Cited by 101
Vey, N., Delaunay, J., Martinelli, G., Fiedler, W., Raffoux, E., Prébet, T., Gomez‐Roca, C., Papayannidis, C., Kebenko, M., Paschka, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8687 · Cited by 101
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy
Dama, P., Tang, M., Fulton, N. C., Kline, J. P., & Liu, H. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0611-3 · Cited by 101
Li, H., Ding, J., Lü, M., Liu, H., Miao, Y., Li, L., Wang, G., Zheng, J., Pei, D., & Zhang, Q. (2019) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000301 · Cited by 101
The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells
Hütz, K., Mejías‐Luque, R., Farsakova, K., Ogris, M., Krebs, S., Anton, M., Vieth, M. W., Schüller, U., Schneider, M. R., Blum, H., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt410 · Cited by 100
Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds
Maiuthed, A., Chantarawong, W., & Pithi Chanvorachote, B. (2018) · Anticancer Research · doi:10.21873/anticanres.12663 · Cited by 100
Rupp, U., Schoendorf-Holland, E., Eichbaum, M. H. R., Schütz, F., Lauschner, I., Schmidt, P., Staab, A., Hanft, G., Huober, J., Sinn, H., et al. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32801403f4 · Cited by 99
Ågerstam, H., Hansen, N., von Palffy, S., Sandén, C., Reckzeh, K., Karlsson, C., Lilljebjörn, H., Landberg, N., Askmyr, M., Högberg, C., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679985 · Cited by 98
Yang, R., Fu, C., Fang, J.-Z., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s121249 · Cited by 98
Song, Y. N., Cai, H., Yin, T., Huo, M., Ma, P., Zhou, J., & Lai, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s155383 · Cited by 98
The Emergence of Universal Immune Receptor T Cell Therapy for Cancer
Minutolo, N. G., Hollander, E. E., & Powell, D. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00176 · Cited by 98
Khoury, T., Ademuyiwa, F. O., Chandraseekhar, R., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.172 · Cited by 96
Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines
Yan, X., Luo, H., Zhou, X., Zhu, B., Wang, Y., & BIAN, X. (2013) · Oncology Reports · doi:10.3892/or.2013.2784 · Cited by 96
Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy
Hu, T., Zhou, R., Zhao, Y., & Wu, G. (2016) · Scientific Reports · doi:10.1038/srep33376 · Cited by 96
Yeruva, S. L. H., Zhao, F., Miller, K. D., Tevaarwerk, A. J., Wagner, L. I., Gray, R. J., Sparano, J. A., & Connolly, R. M. (2018) · npj Breast Cancer · doi:10.1038/s41523-017-0053-3 · Cited by 96
Pellicano, F., Scott, M. T., Helgason, G. V., Hopcroft, L. E. M., Allan, E. K., Aspinall-O’Dea, M., Copland, M., Pierce, A., Huntly, B. J. P., Whetton, A. D., et al. (2014) · Stem Cells · doi:10.1002/stem.1748 · Cited by 95
GLI2 inhibition abrogates human leukemia stem cell dormancy
Sadarangani, A., Pineda, G., Lennon, K. M., Chun, H.-J. E., Shih, A. Y., Schairer, A., Court, A., Goff, D., Prashad, S., Geron, I., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0453-9 · Cited by 95
The cell of origin and the leukemia stem cell in acute myeloid leukemia
Chopra, M., & Bohlander, S. K. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22805 · Cited by 95
Oct4, a novel marker for human gastric cancer
Chen, Z., Xu, W., Qian, H., Zhu, W., Bu, X., Wang, S., Yan, Y., Mao, F., Gu, H., Cao, H., et al. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21270 · Cited by 93
Vasu, S., He, S., Cheney, C., Gopalakrishnan, B., Mani, R., Lozanski, G., Mo, X., Groh, V., Whitman, S. P., Konopitzky, R., et al. (2016) · Blood · doi:10.1182/blood-2015-11-680546 · Cited by 93
Zhou, H., Mak, P. Y., Mu, H., Mak, D. H. F., Zeng, Z., Cortes, J. E., Liu, Q., Andreeff, M., & Carter, B. Z. (2017) · Leukemia · doi:10.1038/leu.2017.87 · Cited by 93
Chang, T., Wu, Y.-C., Chi, C., Su, W.-C., Chang, P., Lee, K.-F., Tung, T.-H., Wang, J., Liu, J., Tung, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3274 · Cited by 92
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
Xiang, D., Shigdar, S. L., Bean, A. G. D., Bruce, M. P., Yang, W. R., Mathesh, M., Wang, T., Yin, W., Tran, P. H. L., Shamaileh, H. A., et al. (2017) · Theranostics · doi:10.7150/thno.20168 · Cited by 92
Shen, W., Liu, L., & Zeng, S. (2018) · Cancer translational medicine · doi:10.4103/ctm.ctm_22_18 · Cited by 92
Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma
Lin, T., Ding, Y., & Li, J. (2011) · Medical Oncology · doi:10.1007/s12032-011-9860-9 · Cited by 91
Phototheranostics of CD44-positive cell populations in triple negative breast cancer
Jin, J., Krishnamachary, B., Mironchik, Y., Kobayashi, H., & Bhujwalla, Z. M. (2016) · Scientific Reports · doi:10.1038/srep27871 · Cited by 90
Wagner, J. L., Damaschke, N., Yang, B., Truong, M., Guenther, C. M., McCormick, J. R., Huang, W., & Jarrard, D. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124366 · Cited by 89
Kim, R., Park, J.-R., Roh, K., Choi, A.-R., Kim, S., Kim, P.-H., Yu, J. H., Lee, J. W., Ahn, S. H., Gong, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.026 · Cited by 89
Sparano, J. A., Gray, R. J., Oktay, M. H., Entenberg, D. R., Rohan, T. E., Xue, X., Donovan, M., Peterson, M., Shuber, A. P., Hamilton, D. A., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0043-5 · Cited by 89
Knödler, M., Körfer, J., Kunzmann, V., Trojan, J., Daum, S., Schenk, M., Kullmann, F., Schroll, S., Behringer, D. M., Stahl, M., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0150-6 · Cited by 89
Boesch, M., Spizzo, G., & Seeber, A. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0289 · Cited by 88
Zhang, B.-L., Li, D., Gong, Y.-L., Huang, Y., Qin, D.-Y., Jiang, L., Liang, X., Yang, X., Gou, H.-F., Wang, Y.-S., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.229 · Cited by 88
Cancer stem cells in small cell lung cancer.
Codony‐Servat, J., Verlicchi, A., & Rosell, R. (2016) · PubMed · doi:10.3978/j.issn.2218-6751.2016.01.01 · Cited by 87
Stem Cell-Like Circulating Tumor Cells Indicate Poor Prognosis in Gastric Cancer
Li, M., Zhang, B., Zhang, Z., et al. (2014) · BioMed Research International · doi:10.1155/2014/981261 · Cited by 84
Su, J. S., Wu, S., Wu, H., et al. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22443 · Cited by 84
Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers
Oikawa, T. (2016) · Hepatology · doi:10.1002/hep.28485 · Cited by 84
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia
Bonifant, C. L., Szöőr, Á., Torres, D., Joseph, N. P., Velasquez, M. P., Iwahori, K., Gaikwad, A. S., Nguyen, P., Arber, C., Song, X., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.116 · Cited by 84
Darwish, N. H. E., Sudha, T., Godugu, K., Elbaz, O., Abdel-ghaffar, H. A., Hassan, E. E. A., & Mousa, S. A. (2016) · Oncotarget · doi:10.18632/oncotarget.11063 · Cited by 84
SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium
Perekatt, A. O., Shah, P., Cheung, S., Jariwala, N. H., Wu, A., Gandhi, V., Kumar, N., Feng, Q., Patel, N. R., Chen, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0043 · Cited by 84
Long, F., He, Y., Fu, H., Li, Y., Bao, X., Wang, Q., Wang, Y., Xie, C., & Lou, L. (2019) · Cancer Science · doi:10.1111/cas.13957 · Cited by 84
Zhou, J., Chen, Q., Zou, Y., Chen, H., Qi, L., & Chen, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00820 · Cited by 84
Spillane, J. B., & Henderson, M. A. (2007) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2007.04096.x · Cited by 83
Colnot, D. R., Quak, J. J., Roos, J. C., et al. (2000) · PubMed · Cited by 83
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer
Jahchan, N. S., Lim, J. S., Bola, B. M., Morris, K. L., Seitz, G., Tran, K. Q. T., Xu, L., Trapani, F., Morrow, C. J., Cristea, S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.021 · Cited by 83
Agrawal, S., Dwivedi, M., Ahmad, H., Chadchan, S. B., Arya, A. K., Sikandar, R., Kaushik, S., Mitra, K., Jha, R. K., & Dwivedi, A. K. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.010 · Cited by 83
von Felden, J., Schulze, K., Krech, T., Ewald, F., Nashan, B., Pantel, K., Lohse, A. W., Riethdorf, S., & Wege, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21208 · Cited by 82
NOTCH3 expression is linked to breast cancer seeding and distant metastasis
Leontovich, A. A., Jalalirad, M., Salisbury, J. L., Mills, L., Haddox, C. L., Schroeder, M. A., Tuma, A. C. M., Guicciardi, M. E., Zammataro, L. A., Gambino, M. W., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1020-0 · Cited by 82
Molecular markers in circulating tumour cells from metastatic colorectal cancer patients
Gazzaniga, P., Gradilone, A., Petracca, A., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01117.x · Cited by 81
Poli, V., Fagnocchi, L., & Zippo, A. (2018) · Stem Cells International · doi:10.1155/2018/4598195 · Cited by 81
Luo, J., Wang, P., Wang, R., Wang, J., Liu, M., Xiong, S., Li, Y., & Cheng, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6672 · Cited by 80
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
Xue, L., Mao, X., Ren, L., & Chu, X. (2017) · Cancer Medicine · doi:10.1002/cam4.1085 · Cited by 80
Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer
Leng, Z., Xia, Q., Chen, J., Li, Y., Xu, J., Zhao, E., Zheng, H., Ai, W., & Dong, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488743 · Cited by 80
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
Long, K. B., Young, R. M., Boesteanu, A. C., Suhoski, M. M., Melenhorst, J. J., Lacey, S. F., Degaramo, D. A., Levine, B. L., & Fraietta, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02740 · Cited by 80
Asai, R., Tsuchiya, H., Amisaki, M., Makimoto, K., Takenaga, A., Sakabe, T., Hoi, S., Koyama, S., & Shiota, G. (2019) · Cancer Medicine · doi:10.1002/cam4.1968 · Cited by 80
Wang, T., Song, P., Zhong, T., Wang, X., Xiang, X., Liu, Q., Chen, H., Xia, T., Liu, H., Niu, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0763-0 · Cited by 80
Hashimoto, K., Aoyagi, K., Isobe, T., et al. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0255-9 · Cited by 79
Quéré, R., Andradottír, S., Brun, A. C. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.281 · Cited by 79
Miragaya, J. G., Palafox, M., Paré, L., Yoldi, G., Ferrer, I., Vila, S., Galván, P., Pellegrini, P., Perez‐Montoyo, H., Igea, A., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.026 · Cited by 79
Stroomer, J. W. G., Roos, J. C., Sproll, M., et al. (2000) · PubMed · Cited by 78
Chakradeo, S., W. Elmore, L., & A. Gewirtz, D. (2016) · Current Drug Targets · doi:10.2174/1389450116666150825113500 · Cited by 78
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
Kozovská, Z., Patsalias, A., Bajzik, V., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4572-6 · Cited by 78
Doherty, M. R., Parvani, J. G., Tamagno, I., Junk, D. J., Bryson, B. L., Cheon, H. J., Stark, G. R., & Jackson, M. W. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1136-x · Cited by 78
Lung cancer stem cells—characteristics, phenotype
Hardavella, G. F., George, R., & Sethi, T. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.02.01 · Cited by 77
Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer
Kodama, H., Murata, S., Ishida, M., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.401 · Cited by 77
Waś, H., Czarnecka‐Herok, J., Kominek, A., Barszcz, K., Bernaś, T., Piwocka, K., & Kaminska, B. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1385675 · Cited by 77
Kovtun, Y., Noordhuis, P., Whiteman, K. R., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1077 · Cited by 77
Intratumoral Heterogeneity in a Trp53 -Null Mouse Model of Human Breast Cancer
Zhang, M., Tsimelzon, A. I., Chang, C.-H., Fan, C., Wolff, A., Perou, C. M., Hilsenbeck, S. G., & Rosen, J. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1101 · Cited by 76
Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones
Al‐Mawali, A., Gillis, D., & Lewis, I. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0292-z · Cited by 76
Basati, G., Mohammadpour, H., & Razavi, À. E. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-00200-x · Cited by 76
Oberschmidt, O., Morgan, M. A., Huppert, V., Kessler, J., Gardlowski, T., Matthies, N., Aleksandrova, K., Arseniev, L., Schambach, A., Koehl, U., et al. (2019) · Human Gene Therapy Methods · doi:10.1089/hgtb.2019.039 · Cited by 75
Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia
Zhou, J. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i4.473 · Cited by 74
Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment
Li, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5420 · Cited by 74
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML
Sadovnik, I., Hoelbl‐Kovacic, A., Herrmann, H., Eisenwort, G., Cerny‐Reiterer, S., Warsch, W., Hoermann, G., Greiner, G., Blatt, K., Peter, B., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0767 · Cited by 74
CD44 promotes cell proliferation in non-small cell lung cancer
Hu, B., Ma, Y., Yang, Y., Zhang, L., Han, H., & Chen, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.8051 · Cited by 74
Rabinovich, Í., Sebastião, A. P. M., de Lima, R. S., et al. (2018) · European Journal of Histochemistry · doi:10.4081/ejh.2018.2943 · Cited by 74
Jang, E., Kim, E., Son, H. Y., Lim, E., Lee, H., Choi, Y., Park, K., Han, S., Suh, J., Huh, Y., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.036 · Cited by 73
Landberg, N., von Palffy, S., Askmyr, M., Lilljebjörn, H., Sandén, C., Rissler, M., Mustjoki, S. M., Hjorth‐Hansen, H., Richter, J., Ågerstam, H., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.169946 · Cited by 73
He, S., Zhou, H., Zhu, X., Hu, S., Fei, M., Wan, D., Gu, W., Yang, X., Shi, D., Zhou, J., et al. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.03.016 · Cited by 72
SALL4 as a new biomarker for early colorectal cancers
Khales, S. A., Abbaszadegan, M. R., Abdollahi, A., Raeisossadati, R., Tousi, M. F., & Forghanifard, M. M. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1808-y · Cited by 72
Jiang, Y.-P., Liu, B. Y., Zheng, Q., Panuganti, S., Chen, R., Zhu, J., Mishra, M., Huang, J., Dao-Pick, T., Roy, S., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018020107 · Cited by 71
Emerging Roles of p53 Related lncRNAs in Cancer Progression: A Systematic Review
Lin, T., Hou, P., Meng, S., Chen, F., Jiang, T., Li, M.-L., Shi, M., Liu, J.-J., Zheng, J., & Bai, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33218 · Cited by 71
Lymphoma stem cells: enough evidence to support their existence?
Martinez-Climent, J. A., Fontán, L., Gascoyne, R. D., Siebert, R., & Prósper, F. (2010) · Haematologica · doi:10.3324/haematol.2009.013318 · Cited by 69
Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma
Zhao, M., Zhang, Y., Zhang, H., Wang, S., Zhang, M., Chen, X., Wang, H., Zeng, G., Chen, X., Liu, G., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.11.017 · Cited by 69
The Origins of Gastric Cancer From Gastric Stem Cells: Lessons From Mouse Models
Hayakawa, Y., Fox, J. G., & Wang, T. C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.01.013 · Cited by 69
Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery
Luo, Y., Wang, X., Du, D., & Lin, Y. (2015) · Biomaterials Science · doi:10.1039/c5bm00067j · Cited by 67
Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer
Zhou, J.-Y., Chen, M., Ma, L., Wang, X., Chen, Y.-G., & Liu, S.-L. (2016) · Oncotarget · doi:10.18632/oncotarget.7084 · Cited by 67
Qiu, Y., Zhou, B., Yang, X., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b02793 · Cited by 67
Yang, F., Wang, Q., Lin, G., Shi, Y., Gu, Z., & Ding, T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.08.034 · Cited by 66
Biomarkers of aging associated with past treatments in breast cancer survivors
Scuric, Z., Carroll, J., Bower, J. E., Ramos-Perlberg, S., Petersen, L., Esquivel, S., Hogan, M., Chapman, A. M., Irwin, M. R., Breen, E. C., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0050-6 · Cited by 66
Joseph, C., Arshad, M., Kurozomi, S., Althobiti, M. M., Miligy, I. M., Al-izzi, S., Toss, M. S., Goh, F. Q., Johnston, S. J., Martin, S. G., et al. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-05085-9 · Cited by 66
Biomarkers of Cell Senescence Assessed by Imaging Cytometry
Zhao, H., & Darżynkiewicz, Z. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-239-1_5 · Cited by 65
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
Han, Shin, D. H., Kim, J. S., Weon, K. Y., Jang, C.-Y., & Kim, J.-S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95850 · Cited by 65
Dai, M., Yuan, F., Fu, C., Shen, G., Hu, S., & Shen, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175357 · Cited by 65
Wang, N., Wang, L., Li, Y., Fu, S.-Y., Xue, X., Jia, L.-N., Yuan, X., Wang, Y., Tang, X., Yang, J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.004 · Cited by 65
Premalignant lesions and gastric cancer: Current understanding
Koulis, A., Buckle, A. D., & Boussioutas, A. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i9.665 · Cited by 65
Waś, H., Barszcz, K., Czarnecka‐Herok, J., Kowalczyk, A., Bernaś, T., Użarowska, E., Koza, P., Klejman, A., Piwocka, K., Kaminska, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14066 · Cited by 64
Wang, Z., Sau, S., Alsaab, H. O., & Iyer, A. K. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.04.004 · Cited by 64
Matsunaga, N., Ogino, T., Hara, Y., Tanaka, T., Koyanagi, S., & Ohdo, S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-4034 · Cited by 64
Single tube liquid biopsy for advanced non‐small cell lung cancer
de Wit, S., Rossi, E. M. C., Weber, S., Tamminga, M., Manicone, M., Swennenhuis, J. F., Groothuis‐Oudshoorn, C. G. M., Vidotto, R., Facchinetti, A., Zeune, L. L., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32056 · Cited by 64
Xi, H. Q., Cai, A., Wu, X., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.112 · Cited by 63
Jin, B., Wang, C., Li, J., Du, X., Ding, K., & Pan, J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0226 · Cited by 63
Thokala, R., Olivares, S., Mi, T., Maiti, S. N., Deniger, D. C., Huls, H. M., Torikai, H., Singh, H., Champlin, R. E., Laskowski, T. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159477 · Cited by 63
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
Tsunekuni, K., Konno, M., Haraguchi, N., Koseki, J., Asai, A., Matsuoka, K., Kobunai, T., Takechi, T., Doki, Y., Mori, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50968-6 · Cited by 63
Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
Ozawa, M., Ichikawa, Y., Zheng, Y.-W., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.253 · Cited by 62
Senescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 62
Dou, X., Liang, Y., Lin, H., Wei, X., Zhang, Y., Bai, J., Chen, C., Chen, M., Du, C., Li, Y., et al. (2017) · Theranostics · doi:10.7150/thno.19989 · Cited by 62
Yu, J., Wang, S., Zhao, W., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1932 · Cited by 62
Wang, B., Chen, Q., Cao, Y., Ma, X., Yin, C., Jia, Y., Zang, A., & Fan, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168904 · Cited by 61
Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML
Valent, P., Sadovnik, I., Eisenwort, G., Bauer, K., Herrmann, H., Gleixner, K. V., Schulenburg, A., Rabitsch, W., Sperr, W. R., & Wolf, D. G. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174233 · Cited by 60
Li, Y., Guo, Y., Bo, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5714 · Cited by 59
Ep CAM expression in breast cancer cells is associated with enhanced bone metastasis formation
Hiraga, T., Ito, S., & Nakamura, H. (2015) · International Journal of Cancer · doi:10.1002/ijc.29921 · Cited by 59
Tarlock, K., Alonzo, T. A., Gerbing, R. B., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1349 · Cited by 59
Knutson, K. L., Clynes, R., Shreeder, B., Yeramian, P., Kemp, K. P., Ballman, K. V., Tenner, K., Erskine, C. L., Norton, N., Northfelt, D., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3091 · Cited by 59
Vishnubalaji, R., Manikandan, M., Fahad, M., Hamam, R., Alfayez, M. A., Kassem, M. S., Aldahmash, A. M., & Alajez, N. M. (2018) · Oncotarget · doi:10.18632/oncotarget.24420 · Cited by 59
Kang, J. H., Lee, S.-H., Lee, J., Nam, B., Seong, T. W., Son, J., Jang, H., Hong, K. M., Lee, C., & Kim, S. (2016) · Oncotarget · doi:10.18632/oncotarget.10354 · Cited by 58
Yamaguchi, N., Nakayama, Y., & Yamaguchi, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763276 · Cited by 58
Ma, F., Chen, D., Chen, F., Chi, Y., Han, Z., Feng, X., Li, X., & Han, Z. (2015) · Cell Transplantation · doi:10.3727/096368915x687462 · Cited by 57
Yang, C., He, Y., Zhang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3681 · Cited by 57
Hoang, V. T., Buss, E. C., Wang, W., Hoffmann, I., Raffel, S., Zepeda‐Moreno, A., Baran, N., Wuchter, P., Eckstein, V., Trumpp, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29410 · Cited by 57
Park, E., Park, S. Y., Sun, P.-L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9894 · Cited by 57
Niktoreh, N., Lerius, B., Zimmermann, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.191841 · Cited by 57
Gastric Cancer Stem Cells: Mechanisms and Therapeutic Approaches
Fu, Y., Du, P., Zhao, J., Hu, C., Qin, Y., & Huang, G. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.10.1150 · Cited by 57
Zhao, L., Yang, Y., Zhou, P., Ma, H., Zhao, X., He, X., Wang, T., Zhang, J., Liu, Y., & Zhang, T. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000086 · Cited by 56
Koren, A., Rijavec, M., Kern, I., Sodja, E., Korošec, P., & Čufer, T. (2015) · Stem Cells International · doi:10.1155/2016/9714315 · Cited by 56
Wnt Signaling in Hematological Malignancies
Grainger, S. J., Traver, D. J., & Willert, K. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.11.002 · Cited by 56
CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma
Liu, K., Hao, M., Ouyang, Y., Zheng, J., & Chen, D. (2017) · Scientific Reports · doi:10.1038/srep41499 · Cited by 55
Yamao, T., Yamashita, Y., Yamamura, K., Nakao, Y., Tsukamoto, M., Nakagawa, S., Okabe, H., Hayashi, H., Imai, K., & Baba, H. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07266-2 · Cited by 55
Kahlert, C., Gaitzsch, E., Steinert, G., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2518-9 · Cited by 54
Chen, Y., Lin, P., Ming, Y., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3460-9 · Cited by 54
Nanog: A Potential Biomarker for Liver Metastasis of Colorectal Cancer
Xu, F., Dai, C., Zhang, R., Zhao, Y., Peng, S., & Jia, C. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2182-8 · Cited by 53
Cancer Stem Cell Markers CD44, CD133 in Primary Gastric Adenocarcinoma.
Nosrati, A., Naghshvar, F., & Khanari, S. (2014) · PubMed · Cited by 53
Su, Y.-J., Lin, W., Chang, Y., Wei, K., Liang, C.-L., Chen, S., & Lee, J.-L. (2015) · Oncotarget · doi:10.18632/oncotarget.5703 · Cited by 53
Zhong, Y., Shen, S., Zhou, Y., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0864-0 · Cited by 53
Watanabe, T., Okumura, T., Hirano, K., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.5432 · Cited by 53
Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse
Dou, Z., & Berger, S. L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.009 · Cited by 53
Satar, N. A., Fakiruddin, K. S., Lim, M. N., Mok, P. L., Zakaria, N., Fakharuzi, N. A., Rahman, A. Z. A., Zakaria, Z., Yahaya, B. H., & Baharuddin, P. (2018) · Oncology Reports · doi:10.3892/or.2018.6461 · Cited by 53
Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
Li, L., Li, J.-C., Yang, H., Zhang, X., Liu, L., Li, Y., Zeng, T., Zhu, Y.-H., Li, X.-D., Li, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806219115 · Cited by 53
Barnawi, R., Al‐Khaldi, S., Çolak, D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32183 · Cited by 53
Liu, X., Lin, X.-K., Mei, Y., Ahmad, S., Yan, C., Jin, H., Yu, H. J., Chen, C., Lin, C., & Yu, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01741 · Cited by 53
CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells
Zhao, Y., Masiello, D., McMillian, M., Nguyen, C., Wu, Y., Melendez, E., Smbatyan, G., Kida, A., He, Y. J., Teo, J.-L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.438 · Cited by 52
Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
Luo, Y., & Tan, Y. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0325-2 · Cited by 52
Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation
Srinivasan, M., Bharali, D. J., Sudha, T., Khedr, M., Guest, I., Sell, S., Glinsky, G. V., & Mousa, S. A. (2017) · Oncotarget · doi:10.18632/oncotarget.16317 · Cited by 52
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Shamaileh, H. A., Wang, T., Xiang, D., Yin, W., Tran, P. H. L., Barrero, R. A., Zhang, P., Li, Y., Kong, L., Liu, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05859-z · Cited by 52
Chen, H., Lin, J., Shan, Y., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108857 · Cited by 52
Landberg, N., Hansen, N., Askmyr, M., Ågerstam, H., Lassen, C., Rissler, M., Hjorth‐Hansen, H., Mustjoki, S. M., Järås, M., Richter, J., et al. (2015) · Leukemia · doi:10.1038/leu.2015.135 · Cited by 51
Fujikuni, N., Yamamoto, H., Tanabe, K., Naito, Y., Sakamoto, N., Tanaka, Y., Yanagihara, K., Oue, N., Yasui, W., & Ohdan, H. (2014) · Cancer Science · doi:10.1111/cas.12522 · Cited by 51
Tian, Y., Zhang, H., Qin, Y., Li, D., Liu, Y., Wang, H., & Gan, L. (2018) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2018.1512613 · Cited by 51
Sowa, T., Menju, T., Sonobe, M., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.556 · Cited by 50
Sun, F.-F., Hu, Y., Xiong, L.-P., Tu, X.-Y., Zhao, J.-H., Chen, S., Song, J., & Ye, X. (2015) · Europe PMC (PubMed Central) · Cited by 50
Liu, D., Du, L., Chen, D., Ye, Z., Duan, H., Tu, T., Feng, J., Yang, Y., Chen, Q., & Yan, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9930 · Cited by 50
Gao, W., Huang, T., Yuan, H., Yang, J. X., Jin, Q., Jia, C., Mao, G., & Zhao, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.03.083 · Cited by 50
Yang, F., Zhang, J., & Yang, H. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s173522 · Cited by 50
Chen, J., He, H., Deng, C., Yin, L., & Zhong, Z. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.040 · Cited by 50
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells
Fujita, T., Chiwaki, F., Takahashi, R., Aoyagi, K., Yanagihara, K., Nishimura, T., Tamaoki, M., Komatsu, M., Komatsuzaki, R., Matsusaki, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130808 · Cited by 49
Lü, L., Wu, M., Sun, L., et al. (2016) · Medicine · doi:10.1097/md.0000000000005163 · Cited by 49
Han, L., Jorgensen, J. L., Brooks, C. L., Shi, C., Zhang, Q., Nogueras‐González, G. M., Cavazos, A., Pan, R. A., Mu, H. H., Wang, S. A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1904 · Cited by 49
Ramaiah, M. J., & Sakthiprasad, V. (2018) · Gene · doi:10.1016/j.gene.2018.08.022 · Cited by 49
CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis
Jiang, Q., Sun, Y. T., & Liu, X. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1637941 · Cited by 49
Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia
Kikushige, Y., & Miyamoto, T. (2015) · Oncology · doi:10.1159/000431062 · Cited by 48
Brugnoli, F., Grassilli, S., Piazzi, M., Palomba, M. L., Nika, E., Bavelloni, A., Capitani, S., & Bertagnolo, V. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-165 · Cited by 48
The miR‐200b–ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma
Tsai, S., Lin, C., Shih, T., Tseng, R.-Y., Yu, M., Lin, Y., & Hsieh, S. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22657 · Cited by 48
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
Leuci, V., Casucci, M., Grignani, G., Rotolo, R., Rossotti, U., Vigna, E., Gammaitoni, L., Mesiano, G., Fiorino, E., Donini, C., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1423167 · Cited by 48
Zhou, J., Sun, M., Jin, S., Fan, L., Zhu, W., Sui, X., Cao, L., Yang, C., & Han, C. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1580799 · Cited by 48
Wu, X., & Huang, S. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.03.012 · Cited by 48
Masciale, V., Grisendi, G., Banchelli, F., D’Amico, R., Maiorana, A., Sighinolfi, P., Stefani, A., Morandi, U., Dominici, M., & Aramini, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01394 · Cited by 48
Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs
Liu, L., Yin, B., Yi, Z., Liu, X., Hu, Z., Gao, W., Yu, H.-W., & Li, Q. (2018) · Breast Cancer · doi:10.1007/s12282-018-0880-6 · Cited by 47
Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Kim, B. H., Park, J., Kim, J. S., et al. (2019) · Gut and Liver · doi:10.5009/gnl18345 · Cited by 47
The CML stem cell: Evolution of the progenitor
Stuart, S. A., Minami, Y., & Wang, J. Y. J. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8209 · Cited by 46
Chen, L., Peng, M., Li, N., Song, Q., Yao, Y., Xu, B., Liu, H., & Ruan, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-19391-1 · Cited by 46
Suda, K., Murakami, I., Yu, H., Kim, J., Tan, A. C., Mizuuchi, H., Rozeboom, L. M., Ellison, K. E., Rivard, C. J., Mitsudomi, T., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1279 · Cited by 46
Cancer stem cell biomarkers in egfr-mutation–positive non–small-cell lung cancer
Codony-Servat, J., Codony-Servat, C., Cardona, A. F., Giménez-Capitán, A., Drozdowskyj, A., Berenguer, J., Bracht, J. W. P., Ito, M., Karachaliou, N., & Rosell, R. (2019) · Clinical Lung Cancer · doi:10.1016/j.cllc.2019.02.005 · Cited by 46
MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer
Zhou, N., Wang, H., Liu, H., Xue, H., Feng, L., Meng, X.-T., Liang, A., Zhao, Z., Liu, Y.-J., & Qian, H. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0263-1 · Cited by 45
Paradoxical role of SOX2 in gastric cancer.
Carrasco‐García, E., Santos, J. C., García, I., Brianti, M. T., García-Puga, M., Pedrazzoli, J., Matheu, A., & Ribeiro, M. L. (2016) · PubMed Central · Cited by 45
Flagged first, then by citations
Research works printed but not linked: 1
- Berger, 2017, Das Rote Buch: Hämatologie und Internistische Onkologie, 1400
Cited by
Sorted by citations
Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise
Abd, G. M., Laird, M. C., Ku, J. C., & Li, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1227884 · Cited by 41
CD166-specific CAR-T cells potently target colorectal cancer cells
He, S., Li, S., Guo, J., Zeng, X., Liang, D., Zhu, Y., Li, Y., Yang, D., & Zhao, X. (2023) · Translational Oncology · doi:10.1016/j.tranon.2022.101575 · Cited by 30
Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21
Metadata
- Authors
- Walcher, L., Kistenmacher, A.-K., Suo, H., Kitte, R., Dluczek, S., Strauß, A., Blaudszun, A.-R., Yevsa, T., Fricke, S., & Kossatz-Boehlert, U.
- Affiliations
- Fraunhofer Institute for Cell Therapy and Immunology (DE)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Yevsa, Tetyana
- Kossatz-Boehlert, Uta
- ORCID
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-08-07
- Volume
- 11
- Pages
- 1280-1280
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7426526
- OpenAlex
- W3047693299
- Cited by
- 1,007
- References
- 603
- Citations by year
- 2026: 75 · 2025: 177 · 2024: 284 · 2023: 244 · 2022: 170 · 2021: 52 · 2020: 5
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion, other-oa)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (YE 151/2-1, AOBJ: 618426)
- Fraunhofer-Gesellschaft
- Fritz Thyssen Stiftung (REF.10.16.1.031MN)
- Sächsische Aufbaubank
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- cancer stem cells, tumor recurrence, senescence-associated secretory phenotype, senescence escape, tumor microenvironment, chemoresistance, radiotherapy, chimeric antigen receptor T cells, precision oncology, acute myeloid leukemia, chronic myeloid leukemia, solid tumors, hematologic cancer
- MeSH terms
- Animals, Combined Modality Therapy, Disease Susceptibility, Humans, Neoplasms, Organ Specificity, Prognosis, Biomarkers, Tumor, Neoplastic Stem Cells, Biomarkers, Immunotherapy, Adoptive, Cellular Senescence, Disease Progression, Drug Resistance, Neoplasm, Disease Management, Molecular Diagnostic Techniques, Precision Medicine, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
